-
Cytokine Growth Factor Rev. · Aug 2017
ReviewImmune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences.
- Luana Calabrò, Giovanni Luca Ceresoli, Armida D'Incecco, Arnaud Scherpereel, Joachim Aerts, and Michele Maio.
- Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: l.calabro@ao-siena.toscana.it.
- Cytokine Growth Factor Rev. 2017 Aug 1; 36: 25-31.
AbstractTreatment with immune-checkpoint blocking monoclonal antibody (mAb) is demonstrating a significant efficacy in different tumor types. Here, we discuss the impact of this promising approach in malignant mesothelioma (MM), a still dreadful disease in which medical treatment has been set on platinum based chemotherapy for decades with unsatisfactory results.Copyright © 2017 Elsevier Ltd. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..